Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Anti-VEGF therapy: the search for clinical biomarkers.

Anti-VEGF therapy: the search for clinical biomarkers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Anti-VEGF therapy: the search for clinical biomarkers. Abstract Text:

    Despite the large diffusion and rapid development of anti-VEGF therapy in clinical practice and in contrast to the consolidated evidence with imatinib and trastuzumab that demonstrated a direct correlation between pre-treatment target expression and drug activity, it is very difficult, at present, to identify validated and useful biomarkers to monitor the efficacy of these compounds and to appropriately select patients most likely to benefit from such treatments. However, emerging data suggest that this is not presently feasible for antiangiogenic drugs. Although tumoral and/or circulating VEGF levels have been associated with tumor progression and/or poor prognosis, to date, there is no validated evidence suggesting their role as potential predictive biomarkers of response to anti-VEGF therapy. Recently, many studies have documented promising results with the evaluation of circulating endothelial cells and/or progenitors, and the use of several imaging techniques, such as dynamic contrast-enhanced MRI, PET, dynamic CT scan and functional ultrasound. These preliminary data need a validation in larger prospective trials.

    Anti-VEGF therapy: the search for clinical biomarkers. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Anti-VEGF therapy: the search for clinical biomarkers. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Expert review of molecular diagnostics

    VOLUME: 8

    Page Numbers: 301-14

    Journal Abbreviation: Expert Rev. Mol. Diagn.

    ISSN: 1744-8352

    DAY: 7

    MONTH: May

    YEAR: 2008

    Anti-VEGF therapy: the search for clinical biomarkers. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101120777

    Anti-VEGF therapy: the search for clinical biomarkers. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Anti-VEGF therapy: the search for clinical biomarkers. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Anti-VEGF therapy: the search for clinical biomarkers.

    AFFILIATION: Division of Medical Oncology, 'San Filippo Neri' Hospital, Via Martinotti 20, 00135 Rome, Italy. raflongo@libero.it

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Rev Mol Diagn

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Anti-VEGF therapy: the search for clinical biomarkers Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News